Staying ahead of the technology curve means strengthening your competitive advantage. That is why we give you data-driven innovation insights into the BioTech industry. This time, you get to discover five hand-picked virology solutions.
Out of 303, the Global Startup Heat Map highlights 5 Top BioTech Startups advancing Virology Solutions
The insights of this data-driven analysis are derived from the Big Data & Artificial Intelligence (AI)-powered StartUs Insights Discovery Platform, covering 2 093 000+ startups & scaleups globally. The platform gives you an exhaustive overview of emerging technologies & relevant startups within a specific field in just a few clicks.
The Global Startup Heat Map below reveals the distribution of the 303 exemplary startups & scaleups we analyzed for this research. Further, it highlights five BioTech startups that we hand-picked based on criteria such as founding year, location, funding raised, and more. You get to explore the solutions of these five startups & scaleups in this report. For insights on the other 298 virology solutions, get in touch with us.
OncoMyx Therapeutics offers Virotherapy
Founding Year: 2018
Location: Phoenix, USA
Funding: USD 75 M
Partner for Cancer Immunotherapy
US-based startup OncoMyx Therapeutics utilizes an oncolytic virus, Myxoma, to target cancer cells. Myxoma is a non-pathogenic poxvirus that is carried by human leukocytes and selectively infects and kills multiple cancer cell types. Myxoma’s large genome allows the insertion of multiple genes into the virus and targets the cancer immunity cycle. The startup administers Myxoma virotherapy via intravenous delivery or its proprietary ex vivo virotherapy. The oncolytic immunotherapy approach activates the immune system to eradicate hematologic and solid tumors, without harming normal cells.
PBD Biotech develops a Rapid Detection Test
Founding Year: 2016
Location: Suffolk, UK
Funding: USD 3,1 M
Work with PBD Biotech to develop Veterinary Diagnostics
British startup PBD Biotech provides phage-based diagnostic technology for the veterinary sector. The startup develops Actiphage, a diagnostic test for tuberculosis and Johne’s disease. Actiphage uses a virus to detect the presence of live mycobacteria in a few hours. This facilitates isolating the infected animal before it becomes infectious. Actiphage is also used to test milk, providing quality assurance for dairy products. The startup’s solution has applications in agriculture, food processing, and the human-health sector.
EcoPhage provides Phage-based Biocontrol
Founding Year: 2019
Location: Ness Ziona, Israel
Reach out for Viral Crop Protectants
Israeli startup EcoPhage develops bacteriophages to combat bacterial diseases in crops. The phage-based biocontrol agents are biodegradable and non-toxic to humans, plants, animals, and non-target microbes. The startup identifies a small fraction of phages most suitable “super phages” for crop-phage treatment via high throughput screening, characterization, and selection processes. It currently targets pathogens causing damage in tomato and pepper plants. The startup’s platform provides a sustainable alternative to synthetic pesticides and antibiotics.
Meletios Therapeutics makes Antiviral Molecules
Founding Year: 2020
Location: Paris, France
Funding: USD 4,47 M
Collaborate to tackle Emerging Viral Diseases
French startup Meletios Therapeutics develops antiviral molecules. The startup works on three programs to tackle emerging viruses. The first program includes the development of antiviral drugs that target virus-infected host functions. The second program focuses on a pharmacophore that inhibits viral replication by targeting viral proteins. Finally, Program 3 involves parasitizing the virus with defective viral genomes. This prevents the virus from producing new infectious virions. The startup also develops antiviral molecules that act on SARS-CoV-2 infected cells.
Bluephage provides a Coliphage Indicator Test
Founding Year: 2016
Location: Barcelona, Spain
Funding: EUR 1,1 M
Use this solution for Water Quality Testing
Spanish startup Bluephage offers water quality testing through viral indicator technology. The startup’s ISO Easy Kits provide a patented bacterial host strain for coliphage testing as an alternative to conventional detector tests. The presence of coliphages indicates other viruses present in water, including norovirus, VHA, rotavirus, and adenovirus. Unlike conventional bacterial indicators, this detects the presence of viral pathogens in water. This way, the startup’s products prevent outbreaks of waterborne diseases.
Discover more BioTech Startups
BioTech startups such as the examples highlighted in this report focus on microbiology, cell biology, and biochemistry. While all of these technologies play a major role in advancing the industry, they only represent the tip of the iceberg. To explore more technologies, simply get in touch to let us look into your areas of interest. For a more general overview, you can download our free BioTech Innovation Report to save your time and improve strategic decision-making.
